Activist investor Kaos Capital has called for changes to Capricor Therapeutics' board of directors. The move follows Kaos Capital's recent engagement with the company.
Further details regarding the proposed changes were not immediately available.


Activist investor Kaos Capital has called for changes to Capricor Therapeutics' board of directors.

Activist investor Kaos Capital has called for changes to Capricor Therapeutics' board of directors. The move follows Kaos Capital's recent engagement with the company.
Further details regarding the proposed changes were not immediately available.

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
